PlainRecalls

Accord Biopharma INC

Compiled from official public sources by the publisher.

1 recalls on record · Latest: Jul 8, 2026

Agency notice ledger

Federal filing book Accord Biopharma INC SINGLE · SINGLE-AGENCY

#6,205 of 14,182 · 1 notices · 0.001% archive

  • BOOK 1 notices
  • RANK #6,205 of 14,182
  • SHARE 0.001% archive
  • AGENCY FDA Drug (1)
  • CAT drugs
  • CATS 1 category
  • LATEST Jul 8, 2026
  • PHOTO —

Accord Biopharma INC sits #6,205 of 14,182 (6,205th among 14,182 firms) with 1 federal notices — about 0.001% of the 104,158-record archive. Rank counts issuance frequency, not danger or fault. FDA · CPSC · NHTSA notice stamps for this firm. Read with this firm → · Dominant category →

FDA Drug Moderate Jul 8, 2026

IMULDOSA, (ustekinumab-srlf) Injection, 130 mg/26 mL (5mg/mL), Rx only, Single dose vial, Manufactured by Accord BioPharma Inc., 8041 Arco corporate …

Data Sources

  • Source: FDA + CPSC + NHTSA - federal recall filings naming this firm. Verify with FDA, CPSC, or NHTSA directly.
  • Source: PlainRecalls Manufacturer Index - firm-level aggregation across all three federal recall feeds

Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. Recalls are aggregated across FDA, CPSC and NHTSA filings that name this firm; the total reflects the federal record, not an independent investigation. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.